Web Analytics Made Easy - StatCounter

Premarin Tab Tenders

Get complete information related to latest Premarin Tab Tenders . from India at Classic Tenders. Search the best available tenders from Indian government tenders, domestic Premarin Tab Tenders , private tenders, online tenders, tender invitation notice, business tender notices, online tenders and bidding Premarin Tab Tenders .

Filter
Loading....
Loading....
Loading....
Loading....
Loading....

Bid Submission Date Range
Tender Value

CTN :38554772 Due date: 02 Jan, 202502 Jan, 2025 NA
Tender For supply of re 101 cath lab - everolimus coated drug eluting platinum chromium coronary stents assorted sizes , everolimus eluting cobalt chromium stents with thin strut thickness , everolimus drug eluting cobalt cromium stent , zotarolimus drug eluting coronory stent system with core wire , sirolimus eluting bioresorbable vascular scaffold bvs of , sirolimus eluting coronary side branch stent system with 65um 0.065mm or , sirolimus eluting coronary tapered stent system , sirolimus eluting cobalt chromium coronary stent system , everolimus eluting cobalt chromium coronary stent system , sirolimus drug coated balloon with nanolute techonology low , drug eluting coronory balloon with urea paclitaxal coating assorted sizes , dual drug polymer free everolimus and probucol eluting coronary stents system , covered coronary stent for use in life threatening coronary perforations or , carotid stent system with closed cell design assorted sizes , sirolimus drug eluting cobalt chromium stent with ultrathin strut , sirolimus eluting cobalt chromium coronary stent with advance core wire s , sirolimus eluting cobalt chromium coronary stent with shorter strut , sirolimus eluting cobalt chromium coronary stent with bioresorble bid number/ ( ( ) ): gem/2024/b/5516691 dated/* : 12-12-2024 bid document/ 1 1 / 19

CTN :38421643 Due date: 23 Dec, 202423 Dec, 2024 89.41 Lacs
Tender For supply of drug - dept of med store &heamat, tab sirolimus 1 mg, human prothrombin complex i.e/e.p.500iu each ml consist of total protein 13-41mg/ml active substances factor ii,vii,ix & x, bortezomib 2 mg powder for inj, recombinant factor viii 500 iu (human plasma/albumin free+ viral inactivation through solvent detergent treatment step), tocilizumab 80mg inj /4ml, tobramycin 300mcg respules 5ml, melphalan propylene glycol free ip 50mg injection, inj brentuximab vedotin 50 mg, inj cidofovir 375mg/5ml, inj polatuzumab vedotin 30 mg, luspatercept powder for solution for injection 25mg, luspatercept powder for solution for injection 75mg, enteral feeding powder with protease enzyme 50-100gm botttle (15-25gm protein/bottle), cap netupitant 300mg + polonestron 0.5mg, inj thiotepa 100 mg

CTN :38315451 Due date: 20 Dec, 202420 Dec, 2024 1.00 Crore
Tender For empanelment of cathlab items - des, everolium, fda approved platinum chromium platform poly-vunylicene fluoride, des, everolimus ,fda approved cobalt chromium platform stent length up to 38 mm, des everolimus for approved cto stent cobalt chromium platform stent 2.25mm to 4.25mm diameter, des, everolimus, fda afproved platinum chromium platform, bioabsorbable polymer plga, des, everolimus fda approved cobalt chromium platform stent length from 12 mm upto 38 mm, des, everolimus hypotube halloon technology, fda approved cobalt chromium platform stem length up to 48 mm, des, everolimus, fda approved cto stent cobalt chromium platform, fluoropolymer z:25mm to 4:25mm, des everolimus, only dcgi cobalt chromium platform, 50 micron strut thickness, des everolimus, only ce afproved cobalt chromium platform with 65 to 70 micron strut, des, everolimus, only degi cobalt chromium platform with 60 micron strut, des everolimus, ce/fda/dcgi approved cobalt chromium biodegradable polymer, 60 micron strut with z link technology and tetrinium design with cumulative drug release technology: length: 8.12.16.20,24 28.32.36.40.44.48, des, biolimus fda approved cobalt chromium platform, des biolimus, ce approved cobalt chromium platform, des, biolimus, only dcgi approved cobalt chromium platform 60 micron strut thickness, des zotarolimus, fda approved cobalt chromium platform polymer type-biolinx, des zotarolimus, ce approved cobalt chromium platform polymer type-phosphorylcholine, des zotarolimus, only dcgi cobalt chromium platform hydrophilic polymer, des zotardlimus eluting coronary stent system with core wire and continuous sinsoid technology, des dual drug eluting polymer free stent, bms fda approved cobalt chromium platform, bms only dcgiapproved cobalt chromium platform, bifurcation stent self expanding, nitinol, bifurcation stent balloon expanding, platinum chromium, bifurcation stent sirolimus eluting,cobalt chromium, bifurcation stent paclitaxel eluting,cobalt chromium, tapered des sirolimus coranary stent with biodegradable polymer, des sirolimus, ce and fda approved, cobalt chromium platform, biodegradable plla eluting 60 mcg strut thickness,cumulative drug release technology with high trackability, des sirolimus, ce approved stainless steel platform, des, sirolimus, only dcgi approved stainless steel platform 50 micron strut thicknes, des sirolimis, 65 micron strut hybrid design with proximal main branch segment and distal tapered side branch segment, sirolimus eluting conorary stent system with an 65 um strut thickness, delivery system with manolithic distal shaft design elongated des sirolimus, ce approved, cobalt chromium platform, abluminal biodegradable polymer eluted in the grooves, des,sirolimus, ce approved, cobalt chromium platform,abluminal biodegradable polymer eluted in the grooves, coronary self apposing stent, multilink cobalt-chromium, meshed stent, ptfe covered stent stainless steel, rapid exchange type, sizes 28, 35.4.4.5.4.8mm, usable length 143cm,crimped stent profile 0.068 inch, biodegradable vascular scaffold (bvs) everolimus eluting, biodegradable vascular scaffold (bvs) sirolimus eluting, stainless steel abluminally coated sirolimus eluting coronary stent with microporous surface & low biodegradable polymer with temperature controlled packing and temperature monitoring device-ce approved, polymer free dual drug sirolimus and probucol eluting stent technology with microporous surface abluminal coating and shellac resin with diameters 2mm-4mm and length 8mm-48mm-dcgi approve, cobalt chromium abluminally coated sirolimus eluting coronary stent with microporous surface & low biodegradable polymer -ce approved, stainless steel abluminally coated sirolimus eluting coronary stent with microporous surface & low biodegradable polymer ce approved, des, sirolimus, ce approved stainless steel platform, prma / peva double layer polymer coating for optimal drug release control,90 days drug releasing, flexible stent d
 Loading, Please wait...

Connect us via What's Up